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A 63-year -old woman came with asymptomatic gross hematuria. Bladder tumor on the 
anterior wall was observed by cystoscope. At 22-year-old, bladder augmentation using ileum 
was performed due to the pre-existence of neurogenic bladder, originating from  congenital 
spina bifica. Since the operation, she has been continued clean intermittent catheterization. 
After diagnosis for bladder tumor, transurethral resection of bladder tumor (TURBT) was 
performed. The bladder tumor was pathologically diagnosed as a bladder adenocarcinoma 
and invaded for muscular layer. After the operation, left lung metastasis was found on 
computed tomography. she takes  chemotherapy with gemcitabine and cisplatin (GC therapy). 


































目以降は cisplatin を 75％に減量としたが、
同様に grade4 の好中球減少をきたしたため、
計 4 コースで GC 療法を中止した。化学療法
終了時の CT で左肺転移病巣は消失していた













ため pembrolizumab 中止。再度 GC 療法を
gemcitabine、cisplatin ともに 40% に減量し
て施行したが、倦怠感・経口摂取不良のため
継続することはできなかった。治療開始から
1 年後の 201X ＋ 1 年 5 月、肝転移巣増大に
伴う肝不全が進行し、永眠された。
Thereafter, bladder tumor and left lung metastasis progressed and liver metastasis was also 
found on computed tomography. She takes another chemotherapy with pembrolizumab. After 
3 cycles were finished, the bladder tumor, the left lung metastasis and the liver metastasis 
were progressed on computed tomography. She takes GC therapy again with reduced dose. 
Unfortunatoly, GC therapy was need to be stopped due to anorexia and fatigue. 
Under the circumstances that effective chemotherapy for bladder adenocarcinoma has not 
been established yet, we experienced a case with bladder adenocarcinoma, treated the 




































図 1  膀 胱 鏡 画 像 （ 左 ）  膀 胱 M R I 水 平 断






































図 3  G C 療 法 施 行 前 （ 左 ）  G C 療 法 4 コ




















図 4  G C 療 法 中 止 後 左 肺 転 移 巣 （ 左 ）、 肝




















図 5  p e m b r o l i z u m a b 3 コ ー ス 後 間 転
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